Mercury Street Medical Group, PLLC | Butte, MT
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
This is a multi-center, randomized, double-blind, placebo-controlled, parallel group dose-finding study to evaluate the efficacy and safety of CT-388 at low, middle, and high doses in participants with obesity or who are overweight with at least one weight-related comorbidity.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
450 participants in 6 patient groups, including a placebo group
Loading...
Central trial contact
Reference Study ID: CT-388-103 Roche study # : XC45526
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal